Characterizing markets for biopharmaceutical innovations : do biologics differ from small molecules?
Year of publication: |
2010
|
---|---|
Authors: | Trusheim, Mark R. ; Aitken, Murray L. ; Berndt, Ernst R. |
Published in: |
Forum for health economics & policy : an evolving collection of symposia on important health care issues. - Berlin : De Gruyter, ISSN 1558-9544, ZDB-ID 2233218-2. - Vol. 13.2010, 1, p. 1-43
|
Subject: | Innovation | Pharmaindustrie | Pharmaceutical industry | Biotechnologie | Biotechnology | USA | United States | KMU | SME | Biotechnologie-Industrie | Biotechnology industry | Pharmakologie | Pharmacology |
Extent: | graph. Darst. |
---|---|
Type of publication: | Article |
Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
Language: | English |
Notes: | Systemvoraussetzungen: Acrobat Reader |
Other identifiers: | 10.2202/1558-9544.1200 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Pharmaceutical innovation : revolutionizing human health
Landau, Ralph, (1999)
-
Bruzzi, Silvia, (2008)
-
Option framework for the valuation of biopharmaceutical companies
Wörner, Stefan, (2001)
- More ...
-
Characterizing markets for biopharmaceutical innovations : do biologics differ from small molecules?
Trusheim, Mark R., (2010)
-
Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?
Trusheim, Mark R.,
-
Measuring and Modeling Health Care Costs
Abraham, Jean M., (2018)
- More ...